Heart attacks have been the leading cause of death in the United States for more than a century.
They occur when blood flow to part of the heart is suddenly blocked, preventing the heart muscle from receiving enough oxygen.
Without quick treatment, part of the heart can become permanently damaged, and in some cases, the event can be fatal. Heart attacks and strokes together affect millions of people every year, which is why scientists are constantly searching for better ways to prevent these dangerous conditions.
Most current treatments focus on dealing with blood clots after they have already formed. Doctors often use blood-thinning medicines or clot-dissolving drugs to restore blood flow.
These treatments can save lives, but they also come with important risks. Because they interfere with the body’s normal clotting process, they can increase the chance of severe bleeding, especially during surgery or after an injury.
Now, researchers at the Georgia Institute of Technology have discovered a completely different approach. Instead of trying to break up clots after they appear, they have found a way to stop dangerous clots from forming in the first place. Even more surprisingly, they are using an inexpensive drug that has already been available in hospitals for many years.
The drug is called N-acetyl cysteine, usually known as NAC. It is not a new medication. Doctors commonly use NAC to treat people who have taken too much acetaminophen, the pain reliever better known by the brand name Tylenol.
The drug has been used for decades and has a well-established safety record. However, scientists now believe it may have another remarkable benefit: preventing blood clots that can trigger heart attacks and strokes.
To understand why this discovery is important, it helps to know how blood clots form. Blood contains tiny cell fragments called platelets. Their job is to help stop bleeding when a blood vessel is injured.
When they receive signals that a blood vessel is damaged, platelets stick together and form a clot. This process is essential for survival because it prevents excessive blood loss.
Problems arise when clots develop inside blood vessels when they are not needed. These unwanted clots can block blood flow to the heart, brain, or other organs. If blood cannot reach the heart, a heart attack can occur. If the blockage happens in the brain, it can cause a stroke.
An important player in this process is a protein called von Willebrand factor, or VWF. Scientists often compare it to a tightly wound ball of yarn. Under normal conditions, the protein stays folded up. But when blood vessels become damaged or narrowed, the protein unfolds and becomes sticky. It then captures platelets and helps build a clot.
Many existing blood-thinning drugs work by preventing platelets from sticking together. While effective, this approach creates a difficult balance. As Professor David Ku from Georgia Tech explained, medicines that reduce clotting can help prevent heart attacks, but they may also make bleeding much more dangerous.
Professor Ku and his team decided to approach the problem differently. Rather than targeting the platelets, they focused on stopping VWF from becoming sticky in the first place.
Their research showed that NAC can break apart the chemical bonds that allow VWF to unfold. If the protein never becomes sticky, platelets cannot gather together and form dangerous clots.
To test their idea, the researchers created a special laboratory system that mimics how blood flows through narrowed or damaged arteries, the places where harmful clots frequently develop. In this system, NAC completely prevented clot formation. The researchers then tested the drug in mice and observed the same result.
The findings became even more exciting when the team discovered that the protective effect of NAC lasted for about six hours, even after the drug itself had disappeared from the bloodstream. This suggests that the medication may continue protecting blood vessels long after it is given.
The discovery could potentially change how doctors treat people at high risk of heart attacks and strokes. In the future, patients in emergency rooms might receive a simple injection of NAC to reduce the risk of clot formation.
Researchers also believe that one day a daily NAC pill might help keep blood vessels open and reduce the chance of life-threatening events.
Because NAC is already widely used in hospitals and has a long history of safe use, it could move through the approval process much faster than an entirely new drug. Researchers are now hoping to begin human clinical trials and are working with the U.S. Food and Drug Administration to explore this possibility.
If future studies confirm these findings, this inexpensive and familiar medicine could help millions of people avoid heart attacks and strokes. Instead of treating dangerous blood clots after they appear, doctors may one day be able to prevent them from forming at all.
For now, NAC represents a promising new idea that could change the way we protect the heart and brain from some of the world’s deadliest diseases.
If you care about heart health, please read studies about how eating eggs can help reduce heart disease risk, and Vitamin K2 could help reduce heart disease risk.
For more information about health, please see recent studies that olive oil may help you live longer, and Vitamin C linked to lower risk of heart failure.
Copyright © 2026 Knowridge Science Report. All rights reserved.
